Ceapro Inc. Announces Publication of Positive Results for a PGX Processed Drug Delivery System for Accelerated Burn Wound Healing June 15, 2020
Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19 May 26, 2020
Ceapro Inc. Receives Research License from Health Canada Controlled Substances and Cannabis Branch February 14, 2020
Ceapro Inc. Announces Approval from Health Canada for Protocol Expansion of Current Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent February 5, 2020
Ceapro Inc. Secures DTC Eligibility for Publicly Traded Shares Under Ticker OTCQZ: CRPOF January 31, 2020
